Literature DB >> 10605748

Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy.

R W Herzog1, K A High.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10605748

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  8 in total

Review 1.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

2.  Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.

Authors:  Guowei Zhang; Qizhen Shi; Scot A Fahs; Erin L Kuether; Christopher E Walsh; Robert R Montgomery
Journal:  Blood       Date:  2010-05-05       Impact factor: 22.113

Review 3.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 4.  Platelets as delivery systems for disease treatments.

Authors:  Qizhen Shi; Robert R Montgomery
Journal:  Adv Drug Deliv Rev       Date:  2010-07-07       Impact factor: 15.470

5.  Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.

Authors:  Shanan N Emmanuel; J Kennon Smith; Jane Hsi; Yu-Shan Tseng; Matias Kaplan; Mario Mietzsch; Paul Chipman; Aravind Asokan; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

6.  Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.

Authors:  Harrison C Brown; Christopher B Doering; Roland W Herzog; Chen Ling; David M Markusic; H Trent Spencer; Alok Srivastava; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2020-08-17       Impact factor: 5.695

7.  AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.

Authors:  Vidyullatha Vasireddy; Jason A Mills; Rajashekhar Gaddameedi; Etiena Basner-Tschakarjan; Monika Kohnke; Aaron D Black; Krill Alexandrov; Shangzhen Zhou; Albert M Maguire; Daniel C Chung; Helen Mac; Lisa Sullivan; Paul Gadue; Jeannette L Bennicelli; Deborah L French; Jean Bennett
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

8.  Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX.

Authors:  Y Shi; R Falahati; J Zhang; L Flebbe-Rehwaldt; K M L Gaensler
Journal:  Gene Ther       Date:  2013-06-13       Impact factor: 5.250
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.